Blocking central leukotrienes synthesis affects vasopressin release during sepsis

Neuroscience

Volumn 160, Issue 4, 2009, Pages 829-836

  Athayde, L Antunes ^a   Oliveira Pelegrin, G Ravanelli ^a   Nomizo, A ^b   Faccioli, L H ^b   Rocha, M J Alves ^a  

^a Faculdade de Odontologia de Ribeirao Preto   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cecal ligation and puncture; hypothalamus; LTC4 synthase; neurohypophysis; plasma

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARGIPRESSIN; LEUKOTRIENE C4 SYNTHASE; NITRATE; SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEMATOCRIT; HORMONE RELEASE; HYPOTHALAMUS; MALE; MORTALITY; NEUROHYPOPHYSIS; NONHUMAN; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SEPSIS; SODIUM BLOOD LEVEL; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; ARGININE VASOPRESSIN; DISEASE MODELS, ANIMAL; GLUTATHIONE TRANSFERASE; HEMATOCRIT; HYPOTENSION; HYPOTHALAMUS; INDOLES; LEUKOTRIENE C4; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; MALE; NITRIC OXIDE; PITUITARY GLAND, POSTERIOR; RATS; RATS, WISTAR; SEPSIS;

EID: 64649097513     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.004     Document Type: Article

References (44)

1. Anderson M.R., and Blumer J.L. Prognostic markers in sepsis: the role of leukotrienes. Crit Care Med 28 (2000) 3762-3763
2. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
3. Baenkler M., Leykauf M., and John S. Functional analysis of eicosanoids from white blood cells in sepsis and SIRS. J Physiol Pharmacol 57 Suppl 12 (2006) 25-33
4. Benjamim C.F., Canetti C., Cunha F.Q., Kunkel S.L., and Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol 174 (2005) 1616-1620
5. Canetti C., Hu B., Curtis J.L., and Peters-Golden M. Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102 (2003) 1877-1883
6. Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., Ferrario S., Parravicini C., Capra V., Gelosa P., Guerrini U., Belcredito S., Cimino M., Sironi L., Tremoli E., Rovati G.E., Martini C., and Abbracchio M.P. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25 (2006) 4615-4627
7. Coffey M.J., Phare S.M., and Peters-Golden M. Role of leukotrienes in killing of Mycobacterium bovis by neutrophils. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 185-190
8. Corrêa P.B., Pancoto J.A., de Oliveira-Pelegrin G.R., Carnio E.C., and Rocha M.J. Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis. J Neuroimmunol 183 (2007) 17-25
9. Cunningham Jr. E.T., and Sawchenko P.E. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 14 (1991) 406-411
10. Delmas A., Leone M., Rousseau S., Albanese J., and Martin C. Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 9 (2005) 212-222
11. Fishel R.S., Are C., and Barbul A. Vessel injury and capillary leak. Crit Care Med 31 (2003) S502-S511
12. Flamand N., Mancuso P., Serezani C.H., and Brock T.G. Leukotrienes: mediators that have been typecast as villains. Cell Mol Life Sci 64 (2007) 2657-2670
13. Folco G., and Murphy R.C. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 58 (2006) 375-388
14. Henderson Jr. W.R. The role of leukotrienes in inflammation. Ann Intern Med 121 (1994) 684-697
15. Holmes C.L., Patel B.M., Russell J.A., and Walley K.R. Physiology of vasopressin relevant to management of septic shock. Chest 120 (2001) 989-1002
16. Hulting A.L., Lindgren J.A., Hokfelt T., Eneroth P., Werner S., Patrono C., and Samuelsson B. Leukotriene C4 as a mediator of luteinizing hormone release from rat anterior pituitary cells. Proc Natl Acad Sci U S A 82 (1985) 3834-3838
17. Krafte-Jacobs B., Brilli R., Szabo C., Denenberg A., Moore L., and Salzman A.L. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 25 (1997) 1588-1593
18. Lam B.K., Penrose J.F., Freeman G.J., and Austen K.F. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci U S A 91 (1994) 7663-7667
19. Lammers C.H., Schweitzer P., Facchinetti P., Arrang J.M., Madamba S.G., Siggins G.R., and Piomelli D. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem 66 (1996) 147-152
20. Landry D.W., Levin H.R., Gallant E.M., Ashton Jr. R.C., Seo S., D'Alessandro D., Oz M.C., and Oliver J.A. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
21. Landry D.W., and Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med 345 (2001) 588-595
22. Lindgren J.A., Hokfelt T., Dahlen S.E., Patrono C., and Samuelsson B. Leukotrienes in the rat central nervous system. Proc Natl Acad Sci U S A 81 (1984) 6212-6216
23. Maxime V., Siami S., and Annane D. Metabolism modulators in sepsis: the abnormal pituitary response. Crit Care Med 35 (2007) S596-S601
24. Miyamoto T., Lindgren J.A., Hokfelt T., and Samuelsson B. Formation of lipoxygenase products in the rat brain. Adv Prostaglandin Thromboxane Leukot Res 17B (1987) 929-933
25. Morlion B.J., Torwesten E., Kuhn K.S., Puchstein C., and Furst P. Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill. Crit Care Med 28 (2000) 3655-3658
26. Nemzek J.A., Xiao H.Y., Minard A.E., Bolgos G.L., and Remick D.G. Humane endpoints in shock research. Shock 21 (2004) 17-25
27. Nicosia S., Capra V., and Rovati G.E. Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 14 (2001) 3-19
28. Oliveira-Pelegrin G.R., Ravanelli M.I., Branco L.G., and Rocha M.J. Thermoregulation and vasopressin secretion during polymicrobial sepsis. Neuroimmunomodulation 16 (2009) 45-53
29. Pancoto J.A., Correa P.B., Oliveira-Pelegrin G.R., and Rocha M.J. Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture. Auton Neurosci 138 (2008) 57-63
30. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 328 (1993) 1471-1477
31. Peres C.M., de Paula L., Medeiros A.I., Sorgi C.A., Soares E.G., Carlos D., Peters-Golden M., Silva C.L., and Faccioli L.H. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect 9 (2007) 483-489
32. Peters-Golden M., and Brock T.G. 5-Lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids 69 (2003) 99-109
33. Peters-Golden M., and Henderson Jr. W.R. Leukotrienes. N Engl J Med 357 (2007) 1841-1854
34. Serezani C.H., Aronoff D.M., Jancar S., Mancuso P., and Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106 (2005) 1067-1075
35. Serezani C.H., Perrela J.H., Russo M., Peters-Golden M., and Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol 177 (2006) 3201-3208
36. Sharshar T., Blanchard A., Paillard M., Raphael J.C., Gajdos P., and Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 31 (2003) 1752-1758
37. Shimada A., Satoh M., Chiba Y., Saitoh Y., Kawamura N., Keino H., Hosokawa M., and Shimizu T. Highly selective localization of leukotriene C4 synthase in hypothalamic and extrahypothalamic vasopressin systems of mouse brain. Neuroscience 131 (2005) 683-689
38. Siami S., Annane D., and Sharshar T. The encephalopathy in sepsis. Crit Care Clin 24 (2008) 67-82 viii
39. Smedegard G., Hedqvist P., Dahlen S.E., Revenas B., Hammarstrom S., and Samuelsson B. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey. Nature 295 (1982) 327-329
40. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
41. Sprague R.S., Stephenson A.H., Dahms T.E., and Lonigro A.J. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure. Crit Care Clin 5 (1989) 315-329
42. Torres-Duenas D., Benjamim C.F., Ferreira S.H., and Cunha F.Q. Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: effects of the inhibition of nitric oxide production, removal of infectious focus, and antimicrobial treatment. Shock 25 (2006) 267-276
43. Wichterman K.A., Baue A.E., and Chaudry I.H. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29 (1980) 189-201
44. Wolfe L.S. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 38 (1982) 1-14